DB LOGO+Text_2-Color.png
Diamondback Energy, Inc. Schedules Fourth Quarter 2024 Conference Call for February 25, 2025
January 09, 2025 16:01 ET | Diamondback Energy, Inc.
MIDLAND, Texas, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release fourth quarter 2024 financial results on February...
zmc-color-black-horizontal (5).png
Zefiro Methane Corp. Releases Updated Corporate Presentation Reflecting 2024 Growth
January 09, 2025 16:01 ET | Zefiro Methane Corp
FORT LAUDERDALE, Fla., Jan. 09, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”), an environmental services...
Frequency Electronics Inc. To Present at 27th Annual Needham Conference
January 09, 2025 16:01 ET | Frequency Electronics, Inc.
MITCHEL FIELD, N.Y., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, is...
Intellia.jpg
Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z)
January 09, 2025 16:00 ET | Intellia Therapeutics, Inc.
Priority programs – NTLA-2002 for hereditary angioedema (HAE) and nexiguran ziclumeran (nex-z) for transthyretin (ATTR) amyloidosis – set foundation for significant, near-term value creation Phase...
BioV Foundation Logo.png
BioV Life Science and Regenerative Medicine International Summit Successfully Concludes, Leading the Future of Regenerative Medicine
January 09, 2025 16:00 ET | BioV Foundation
Los Angeles, CA, Jan. 09, 2025 (GLOBE NEWSWIRE) -- On December 22, 2024, the "BioV Life Science and Regenerative Medicine International Summit," a significant event in the life sciences field at the...
Hohem Logo.png
Hohem Secures Over $14 Million after a Series B funding round led by Shunwei Capital, Legend Capital, and Xiaomi
January 09, 2025 16:00 ET | Hohem
Shenzhen, China, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Hohem, one of the pioneers in smart imaging, just raised $14 million in a Series B funding round.The round was co-led by Shunwei Capital and Legend...
3i.png
3i Debuts Two Groundbreaking Products at CES 2025: P10 Ultra and G10+ Transform Home Automation
January 09, 2025 16:00 ET | 3i
Las Vegas, NV, Jan. 09, 2025 (GLOBE NEWSWIRE) -- 3i, a leading smart home technology brand, has made a significant impact at CES 2025 by unveiling its latest innovations, the 3i P10 Ultra and 3i...
Mural_Logo.jpg
Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts
January 09, 2025 16:00 ET | Mural Oncology, Inc.
Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal melanoma Preliminary...
Aptose Biosciences Inc. logo
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
January 09, 2025 16:00 ET | Aptose Biosciences, Inc.
Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
BRONSTEIN,-GEWIRTZ-&-GROSSMAN,-LLC-Logo.png
REGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
January 09, 2025 16:00 ET | Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...